您的位置:山东大学 -> 科技期刊社 -> 《山东大学学报(医学版)》

山东大学学报 (医学版) ›› 2023, Vol. 61 ›› Issue (10): 38-45.doi: 10.6040/j.issn.1671-7554.0.2023.0206

• • 上一篇    下一篇

碳酸氢钠对胃镜检查视野清晰度和疾病检出率的影响

李然1,2,郭安兵1,张秀云1,鲁临1,杜超1,2   

  1. 1.青岛大学第十一临床医学院, 临沂市人民医院消化内科 消化内镜中心, 山东 临沂 276000;2.青岛大学研究生院, 山东 青岛 266071
  • 发布日期:2023-11-08
  • 通讯作者: 杜超. E-mail:duchao0608@163.com
  • 基金资助:
    山东省自然科学基金(ZR2021MH183,ZR2021MH362);临沂市人民医院研究生培养基金(YJS2023007)

Effects of sodium bicarbonate on the visual clarity and disease detection rate of gastroscopy

LI Ran1,2, GUO Anbing1, ZHANG Xiuyun1, LU Lin1, DU Chao1,2   

  1. 1. Department of Gastroenterology, Gastrointestinal Endoscopy Centre, Linyi Peoples Hospital, The Eleventh Clinical Medical School of Qingdao University, Linyi 276000, Shandong, China;
    2. Graduate School of Qingdao University, Qingdao 266071, Shandong, China
  • Published:2023-11-08

摘要: 目的 验证行胃镜检查前服用配制的碳酸氢钠溶液可达到与现临床常用祛泡药物大体相当的祛泡效果,且不影响镜下病变的发现率。 方法 本研究是一项双盲、单中心、随机对照试验,共纳入950例行胃镜检查的患者,被随机分配到6组,设定A组、B组、C组为试验组,D组、E组、F组为对照组:A组:1 g碳酸氢钠散融入50 mL 40 ℃温开水;B组:2 g碳酸氢钠散融入50 mL 40 ℃温开水;C组:1 g碳酸氢钠散+3 mL西甲硅油乳剂融入50 mL 40 ℃温开水;D组:20 000 U链霉蛋白酶颗粒(含1 g碳酸氢钠散)+3 mL西甲硅油乳剂融入50 mL 40 ℃温开水(本中心固定胃镜前准备用药);E组:含1.2 g乙酰半胱氨酸+3 mL西甲硅油乳剂融入50 mL 40 ℃温开水;F组:50 mL 40 ℃温开水。术前5 min均常规饮用10 mL盐酸利多卡因胃镜润滑剂麻醉咽喉部,检查完成后由操镜医师填写黏膜清晰度、医师操作满意度评分表,同时记录内镜下诊断,计算总黏膜清晰度评分。 结果 饮用温开水的F组祛泡效果最差,整体黏膜清晰度评分达到5分者仅占2%,达到医师满意者仅为71%,明显低于其他5组。各部位评分及医师操作满意度差异与其他5组相比均有统计学意义(P<0.003)。D组总黏膜清晰度评分达5分占比70%,医师操作满意占比98%,祛泡效果最佳;A组与D组相比,仅总黏膜清晰度评分差异有统计学意义(P<0.003),其他部位评分及医师操作满意度差异均无统计学意义,祛泡效果A组和D组大致相当;A组与C组相比,胃底评分差异有统计学意义(P<0.003),其他部位评分及医师操作满意度差异无统计学意义;C组与D组相比,胃底、胃体、总黏膜清晰度评分差异均有统计学意义(P<0.003),C组总体祛泡效果尚可;A组与B组相比,各部位评分及医师操作满意度差异均有统计学意义(P<0.003),祛泡效果A组明显优于B组;E组与A、C两组相比,各部位评分和医师操作满意度差异均无统计学意义,祛泡效果大致相同;6组镜下病变发现率差异均无统计学意义(P>0.003)。 结论 胃镜检查前服用1 g碳酸氢钠配制的溶液可达到与临床常用祛泡药物大体相当的祛泡效果,且不影响镜下病变发现率。1 g碳酸氢钠祛泡效果优于2 g碳酸氢钠,添加西甲硅油可能无法获得更好成效。碳酸氢钠价格低廉,值得基层医院推广。

关键词: 碳酸氢钠, 西甲硅油, 胃镜检查, 术前用药, 检出率

Abstract: Objective To verify that the administration of sodium bicarbonate solution before gastroscopy can have comparable defoaming effects as the commonly used defoaming medications in clinical practice without affecting the detection rate of endoscopic lesions. Methods In this double-blind, single-center, randomized controlled trial, 950 patients undergoing gastroscopy were involved, who were randomly assigned to 6 groups. A, B, and C were experimental groups, while D, E and F were control groups. In group A, 1 g of sodium bicarbonate was dissolved in 50 mL of warm water at 40 ℃; in group B, 2 g of sodium bicarbonate was dissolved in 50 mL of warm water at 40 ℃; in group C, 1 g of sodium bicarbonate+3 mL of simethicone was dissolved in 50 mL of warm water at 40 ℃; in group D, 20 000 U of pronase(containing 1g of sodium bicarbonate)+3 mL of simethicone was dissolved in 50 mL of warm water at 40 ℃(the fixed gastroscopy premedication in our center); in group E, 1.2 g of N-acetylcysteine(NAC)+3 mL of simethicone was dissolved in 50 mL of warm water at 40 ℃; in group F, 50 mL of warm water at 40 ℃ was used. All patients routinely drank 10 mL of lidocaine gastroscopic lubricant to anesthetize the pharynx 5 min before the procedure. After completion of the examination, the operating physicians filled in a rating form for the mucosal visibility score(MVS)and operational satisfaction score(OSS), recorded the endoscopic diagnosis, and calculated the total mucosal visibility score(TMVS). Results Group F was the least effective in removing blisters; only 2% of the patients had TMVS of 5 and only 71% achieved physician satisfaction, significantly lower than those of the other 5 groups; the differences in scores for each site and physician satisfaction were statistically significant compared to the other 5 groups(P<0.003). Group D was the most effective in removing blisters; 70% of the patients had TMVS of 5, and 98% achieved physician satisfaction. Groups A and D had comparable effects in removing blisters; there was only difference in TMVS(P<0.003). There was only significant difference in MVS of gastric fundus between group A and group C(P<0.003). There were differences in the MVS of gastric fundus, gastric body and TMVS between group C and group D(P<0.003). The overall efficacy of defoaming in Group C was average. Between group A and group B, the differences in all scores were statistically significant(P<0.003), and the efficacy of foam removal was significantly better in group A. No statistically significant differences in all scores were observed among groups E, A and C, and the efficacy of foam removal was approximately the same. There was no significant difference in the detection rate of endoscopic lesions among the 6 groups(P>0.003). Conclusion Administration of 1 g of sodium bicarbonate solution before gastroscopy can achieve approximately the same efficacy as the commonly used defoaming medications without affecting the detection rate of endoscopic lesions. The administration of 1 g is more effective than 2 g, and the addition of simethicone may not yield better results. Sodium bicarbonate is inexpensive and worth promotion in primary hospitals.

Key words: Sodium bicarbonate, Simethicone, Gastroscopy, Premedication, Detection rate

中图分类号: 

  • R573
[1] Kim GH, Cho YK, Cha JM, et al. Efforts to increase image quality during endoscopy: The role of pronase [J]. World J Gastrointest Endosc, 2016, 8(5): 267-272.
[2] Gotoda T, Uedo N, Yoshinaga S, et al. Basic principles and practice of gastric cancer screening using high-definition white-light gastroscopy: Eyes can only see what the brain knows [J]. Dig Endosc, 2016, 28(Suppl 1): 2-15. doi: 10.1111/den.12623.
[3] Chang WK, Yeh MK, Hsu HC, Chen HW, Hu MK. Efficacy of simethicone and N-acetylcysteine as premedication in improving visibility during upper endoscopy[J]. J Gastroenterol Hepatol, 2014, 29(4):769-774.
[4] Neale JR, James S, Callaghan J, et al. Premedication with N-acetylcysteine and simethicone improves mucosal visualization during gastroscopy: a randomized, controlled, endoscopist-blinded study [J]. Eur J Gastroenterol Hepatol, 2013, 25(7): 778-783.
[5] Beg S, Ragunath K, Wyman A, et al. Quality standards in upper gastrointestinal endoscopy: a position statement of the British Society of Gastroenterology(BSG)and Association of Upper Gastrointestinal Surgeons of Great Britain and Ireland(AUGIS)[J]. Gut, 2017, 66(11): 1886-1899.
[6] Woo JG, Kim TO, Kim HJ, et al. Determination of the optimal time for premedication with pronase, dimethylpolysiloxane, and sodium bicarbonate for upper gastrointestinal endoscopy [J]. J Clin Gastroenterol, 2013, 47(5): 389-392.
[7] Monrroy H, Vargas JI, Glasinovic E, et al. Use of N-acetylcysteine plus simethicone to improve mucosal visibility during upper GI endoscopy: a double-blind, randomized controlled trial [J]. Gastrointest Endosc, 2018, 87(4): 986-993.
[8] Chang WK, Yeh MK, Hsu HC, et al. Efficacy of simethicone and N-acetylcysteine as premedication in improving visibility during upper endoscopy [J]. J Gastroenterol Hepatol, 2014, 29(4): 769-774.
[9] Liu X, Guan CT, Xue LY, et al. Effect of premedication on lesion detection rate and visualization of the mucosa during upper gastrointestinal endoscopy: a multicenter large sample randomized controlled double-blind study [J]. Surg Endosc, 2018, 32(8): 3548-3556.
[10] 胡晓飞, 信真真, 崔铮, 等. 链霉蛋白酶联合西甲硅油在微探头超声胃镜检查中的应用[J]. 精准医学杂志, 2022, 37(5): 462-464,470. HU Xiaofei, XIN Zhenzhen, CUI Zheng, et al. Application of pronase combined with simethicone in microprobe ultrasound gastroscopy [J]. Journal of Precision Medicine, 2022, 37(5): 462-464,470.
[11] Wang GX, Liu X, Wang S, et al. Effects of premedication with Pronase for endoscopic ultrasound of the stomach: a randomized controlled trial [J]. World J Gastroenterol, 2016, 22(48): 10673-10679.
[12] Manfredi G, Bertè R, Iiritano E, et al. Premedication with simethicone and N-acetylcysteine for improving mucosal visibility during upper gastrointestinal endoscopy in a Western population [J]. Endosc Int Open, 2021, 9(2): E190-E194.
[13] Mahawongkajit P, Kanlerd A. A prospective randomized controlled trial comparing simethicone, N-acetylcysteine, sodium bicarbonate and peppermint for visualization in upper gastrointestinal endoscopy [J]. Surg Endosc, 2021, 35(1): 303-308.
[14] Kuo CH, Sheu BS, Kao AW, et al. A defoaming agent should be used with pronase premedication to improve visibility in upper gastrointestinal endoscopy [J]. Endoscopy, 2002, 34(7): 531-534.
[15] Chang CC, Chen SH, Lin CP, et al. Premedication with pronase or N-acetylcysteine improves visibility during gastroendoscopy: an endoscopist-blinded, prospective, randomized study [J]. World J Gastroenterol, 2007, 13(3): 444-447.
[16] 汪伟. 不同祛泡剂在胃镜检查前处置中应用效果比较[J]. 吉林医学, 2018, 39(8): 1494-1497. WANG Wei. Comparison of the effects of different defoaming agents in the treatment before gastroscopy [J]. Jilin Medical Journal,2018, 39(8): 1494-1497.
[17] Park JJ, Lee SK, Jang JY, et al. The effectiveness of simethicone in improving visibility during colonoscopy [J]. Hepatogastroenterology, 2009, 56(94-95): 1321-1325.
[18] Burke E, Harkins P, Moriarty F, et al. Does premedication with mucolytic agents improve mucosal visualization during oesophagogastroduodenoscopy: a systematic review and meta-analysis[J]. Surg Res Pract, 2021, 2021: 1570121. doi: 10.1155/2021/1570121.
[19] Lee GJ, Park SJ, Kim SJ, et al. Effectiveness of premedication with pronase for visualization of the mucosa during endoscopy: a randomized, controlled trial [J]. Clin Endosc, 2012, 45(2): 161-164.
[20] 赵艳春, 吴云林, 左利平. 西甲硅油联合糜蛋白酶溶液作胃镜检查术前准备的临床观察[J]. 胃肠病学和肝病学杂志, 2010, 19(11): 1019-1021. ZHAO Yanchun, WU Yunlin, ZUO Liping. Clinical observation of applying solution of simethicone plus chymotrypsin before gastroscopy examination [J]. Chinese Journal of Gastroenterology and Hepatology, 2010, 19(11): 1019-1021.
[21] 徐晓玲, 柴海娜, 孙超, 等. 饮水在普通胃镜术前准备中的疗效观察[J]. 中华消化内镜杂志, 2017, 34(11): 804-806.
[22] Chen X, Dai N, Deng Y, et al. Premedication with reformulated simethicone and sodium bicarbonate improves mucosal visibility during upper gastrointestinal endoscopy: a double-blind, multicenter, randomized controlled trial [J]. BMC Gastroenterol, 2021, 21(1): 124.
[23] Wang C, Liu H, Wang X, et al. Benefit of a 360-degree horizontal turn following premedication with simethicone on image quality during gastroendoscopy: a randomized controlled trial [J]. Int J Clin Exp Med, 2015, 8(3): 4281-4286.
[24] Elvas L, Areia M, Brito D, et al. Premedication with simethicone and N-acetylcysteine in improving visibility during upper endoscopy: a double-blind randomized trial [J]. Endoscopy, 2017, 49(2): 139-145.
[25] Bhandari P, Green S, Hamanaka H, et al. Use of Gascon and Pronase either as a pre-endoscopic drink or as targeted endoscopic flushes to improve visibility during gastroscopy: a prospective, randomized, controlled, blinded trial [J]. Scand J Gastroenterol, 2010, 45(3): 357-361.
[1] 王煜,尹增正,聂晓琨,马志德,熊世江. 1 125颗下颌第一恒磨牙近中中央根管的CBCT检出率及相关因素分析[J]. 山东大学学报 (医学版), 2022, 60(3): 100-109.
[2] 王超,张艺琳,邹广顺,吕军城. 686名医学生有无自杀意念调查及影响因素分析[J]. 山东大学学报 (医学版), 2022, 60(1): 78-85.
[3] 高西美1,王静2,杨晓云1,高立菊3,王凯4. 济南市体检人群脂肪肝检出率及危险因素[J]. 山东大学学报(医学版), 2012, 50(6): 119-121.
[4] 贾春玲,杨学馨,王 磊,李翠荣 . 控制牙菌斑对胃粘膜幽门螺旋杆菌检出率的影响[J]. 山东大学学报(医学版), 2008, 46(8): 807-808.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
[1] 马青源,蒲沛东,韩飞,王超,朱洲均,王维山,史晨辉. miR-27b-3p调控SMAD1对骨肉瘤细胞增殖、迁移和侵袭作用的影响[J]. 山东大学学报 (医学版), 2020, 1(7): 32 -37 .
[2] 张宝文,雷香丽,李瑾娜,罗湘俊,邹容. miR-21-5p靶向调控TIMP3抑制2型糖尿病肾病小鼠肾脏系膜细胞增殖及细胞外基质堆积[J]. 山东大学学报 (医学版), 2020, 1(7): 7 -14 .
[3] 付洁琦,张曼,张晓璐,李卉,陈红. Toll样受体4抑制过氧化物酶体增殖物激活受体γ加重血脂蓄积的分子机制[J]. 山东大学学报 (医学版), 2020, 1(7): 24 -31 .
[4] 龙婷婷,谢明,周璐,朱俊德. Noggin蛋白对小鼠脑缺血再灌注损伤后学习和记忆能力与齿状回结构的影响[J]. 山东大学学报 (医学版), 2020, 1(7): 15 -23 .
[5] 李宁,李娟,谢艳,李培龙,王允山,杜鲁涛,王传新. 长链非编码RNA AL109955.1在80例结直肠癌组织中的表达及对细胞增殖与迁移侵袭的影响[J]. 山东大学学报 (医学版), 2020, 1(7): 38 -46 .
[6] 丁祥云,于清梅,张文芳,庄园,郝晶. 胰岛素样生长因子II在84例多囊卵巢综合征患者颗粒细胞中的表达和促排卵结局的相关性[J]. 山东大学学报 (医学版), 2020, 1(7): 60 -66 .
[7] 索东阳,申飞,郭皓,刘力畅,杨惠敏,杨向东. Tim-3在药物性急性肾损伤动物模型中的表达及作用机制[J]. 山东大学学报 (医学版), 2020, 1(7): 1 -6 .
[8] 肖娟,肖强,丛伟,李婷,丁守銮,张媛,邵纯纯,吴梅,刘佳宁,贾红英. 两种甲状腺超声数据报告系统诊断效能的比较[J]. 山东大学学报 (医学版), 2020, 1(7): 53 -59 .
[9] 史爽,李娟,米琦,王允山,杜鲁涛,王传新. 胃癌miRNAs预后风险评分模型的构建与应用[J]. 山东大学学报 (医学版), 2020, 1(7): 47 -52 .
[10] 郭志华,赵大庆,邢园,王薇,梁乐平,杨静,赵倩倩. Ⅰ期端端吻合术治疗重度颈段气管狭窄临床分析[J]. 山东大学学报 (医学版), 2020, 1(7): 72 -76 .